Pratima Sinha Email

Director, Cell Therapy Process Development . Immunomic Therapeutics

Current Roles

Employees:
38
Revenue:
$2.9M
About
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.
Immunomic Therapeutics Address
15010 Broschart Road
Rockville, MD
United States
Immunomic Therapeutics Email

Past Companies

Immunomic Therapeutics, Inc.Director, Cell Therapy Process Development
Immunomic Therapeutics, Inc.Associate Director, Cell Therapy Operations
Immunomic Therapeutics, Inc.Senior Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.